Cargando…

Rituximab is highly effective for pure red cell aplasia and post-transplant lymphoproliferative disorder after unrelated hematopoietic stem cell transplantation

Pure red cell aplasia (PRCA) and post-transplant lymphoproliferative disorder (PTLD) constitute rare complications after allogeneic hematopoietic stem cell transplantation (AlloHSCT). The incidence of EBV-PTLD is above 1%, but it may increase in patients with well-known risk factors such as EBV sero...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kopińska, Anna, Helbig, Grzegorz, Frankiewicz, Andrzej, Grygoruk-Wiśniowska, Iwona, Kyrcz-Krzemień, Sławomira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2012
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687412/ https://www.ncbi.nlm.nih.gov/pubmed/23788882 http://dx.doi.org/10.5114/wo.2012.29287

Ejemplares similares

Bing-Neel Syndrome with Detectable MYD88 L265P Gene Mutation as a Late Relapse Following Autologous Hematopoietic Stem Cell Transplantation for Waldenström’s Macroglobulinemia
por: Kopińska, Anna J., et al.
Publicado: (2017)

Autologous hematopoietic stem cell transplantation for relapsed follicular lymphoma: safety profile and clinical outcome in a single-center experience
por: Helbig, Grzegorz, et al.
Publicado: (2014)

Autologous stem cell transplantation for mantle cell lymphoma – single centre experience
por: Szcześniak, Magdalena, et al.
Publicado: (2013)

Long-Term Outcome of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Acute Myeloid Leukemia (AML)- Single Center Retrospective Analysis
por: Helbig, Grzegorz, et al.
Publicado: (2017)

Fungal Colonization of the Respiratory Tract in Allogeneic and Autologous Hematopoietic Stem Cell Transplant Recipients: A Study of 573 Transplanted Patients
por: Markowski, Jarosław, et al.
Publicado: (2015)

Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis
por: Helbig, Grzegorz, et al.
Publicado: (2017)

Splenic irradiation before allogeneic stem cell transplantation for myelofibrosis
por: Helbig, Grzegorz, et al.
Publicado: (2019)

Pre-transplant FLT3/ITD status predicts outcome in FLT3-mutated acute myeloid leukemia following allogeneic stem cell transplantation
por: Helbig, Grzegorz, et al.
Publicado: (2020)

Spectacular and Prompt Response to Extracorporeal Photopheresis for Refractory Cutaneous Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report
por: Spałek, Adrianna, et al.
Publicado: (2022)

Treating oral mucositis with a supersaturated calcium phosphate rinse: comparison with control in patients undergoing allogeneic hematopoietic stem cell transplantation
por: Markiewicz, Miroslaw, et al.
Publicado: (2012)

The kinetics of mRNA transforming growth factor beta1 expression and its serum concentration in graft-versus-host disease after allogeneic hemopoietic stem cell transplantation for myeloid leukemias
por: Kyrcz-Krzemień, Sławomira, et al.
Publicado: (2011)

The Presence of Anti-HLA Antibodies before and after Allogeneic Hematopoietic Stem Cells Transplantation from HLA-Mismatched Unrelated Donors
por: Koclega, Anna, et al.
Publicado: (2012)

Allogeneic transplantation for high-risk chronic lymphocytic leukemia—a summary of a 16-year experience
por: Helbig, Grzegorz, et al.
Publicado: (2019)

Autologous Hematopoietic Stem Cell Transplantation for High-risk Acute Lymphoblastic Leukemia: non-Randomized Study with a maximum Follow-up of more than 22 Years
por: Helbig, Grzegorz, et al.
Publicado: (2014)

Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation
por: Jung, Sung-Hoon, et al.
Publicado: (2012)

Pure Red Cell Aplasia and Lymphoproliferative Disorders: An Infrequent Association
por: Vlachaki, Efthymia, et al.
Publicado: (2012)

Resolution of thrombocytopenia, but not polycythemia after ruxolitinib for polycythemia vera with detectable mutation in the exon 12 of the JAK2 gene
por: Helbig, Grzegorz, et al.
Publicado: (2017)

Prevalence of Pure Red Cell Aplasia Following Major ABO-Incompatible Hematopoietic Stem Cell Transplantation
por: Zhu, Panpan, et al.
Publicado: (2022)

The Influence of Genetic Variations in the CD86 Gene on the Outcome after Allogeneic Hematopoietic Stem Cell Transplantation
por: Karabon, Lidia, et al.
Publicado: (2018)

Occurrence and Impact of Minor Histocompatibility Antigens' Disparities on Outcomes of Hematopoietic Stem Cell Transplantation from HLA-Matched Sibling Donors
por: Dzierzak-Mietla, Monika, et al.
Publicado: (2012)

Autologous stem cell transplantation as consolidation therapy for patients with peripheral T cell lymphoma in first remission: long-term outcome and risk factors analysis
por: Czyz, Anna, et al.
Publicado: (2013)

Post renal transplant pure red cell aplasia—is tacrolimus a culprit?
por: Patil, Malagouda R., et al.
Publicado: (2016)

New drugs in multiple myeloma – role of carfilzomib and pomalidomide
por: Jurczyszyn, Artur, et al.
Publicado: (2014)

Coexistence of Chronic Lymphocytic Leukemia and Myeloproliferative Neoplasm
por: Zielinska, Patrycja, et al.
Publicado: (2014)

Clinical relevance of mutant NPM1 and CEBPA in patients with acute myeloid leukaemia – preliminary report
por: Helbig, Grzegorz, et al.
Publicado: (2014)

Characteristics and clinical outcome of patients with hypereosinophilia of undetermined significance
por: Helbig, Grzegorz, et al.
Publicado: (2013)

Outcome of Rituximab-Based Treatment for Post-Transplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Experience
por: Zhu, Cheng-ying, et al.
Publicado: (2019)

MHC Haplotype Matching for Unrelated Hematopoietic Cell Transplantation
por: Petersdorf, Effie W, et al.
Publicado: (2007)

Rituximab: A viable treatment option for epoetin-induced pure red cell aplasia
por: Mahajan, S. A., et al.
Publicado: (2015)

A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation
por: Karabon, Lidia, et al.
Publicado: (2015)

Sustained remission after ABVD treatment for interdigitating dendritic cell sarcoma
por: Helbig, Grzegorz, et al.
Publicado: (2014)

Daratumumab as a Frontline Immunosuppression for Pure Red Cell Aplasia after Major ABO-mismatched Allogeneic Hematopoietic Stem Cell Transplantation
por: Asawapanumas, Thiti, et al.
Publicado: (2022)

Rituximab is Indispensable for Pediatric Heart Transplant Recipients Developing Post Transplant Lymphoproliferative Disorders
por: Karbasi-Afshar, R, et al.
Publicado: (2013)

Treatment of Concurrent Minimal Change Disease and Epstein Barr Virus–Driven Post-transplant Lymphoproliferative Disorder With Rituximab Following Hematopoietic Stem Cell Transplantation
por: Ainley, Louise, et al.
Publicado: (2020)

Hematopoietic Stem Cell Transplantation after Posttransplant Lymphoproliferative Disorder
por: Kim, Min Joo, et al.
Publicado: (2010)

Primary acquired chronic pure red cell aplasia refractory to standard treatments: remission with rituximab
por: Tendas, Andrea, et al.
Publicado: (2016)

Recovery of Pure Red Cell Aplasia Following Hematopoietic Stem Cell Transplantation Associated with Interleukin (IL)-6 Elevation Caused by Odontogenic Infection
por: Nakamura, Nobuhiko, et al.
Publicado: (2018)

Pure red cell aplasia in a simultaneous pancreas-kidney transplantation patient: inside the erythroblast
por: Labbadia, Francesca, et al.
Publicado: (2012)

Anti-Erythropoietin Antibody Associated Pure Red Cell Aplasia Resolved after Liver Transplantation
por: Hung, Annie K., et al.
Publicado: (2015)

Pure red cell aplasia caused by parvovirus B19 in a heart transplant recipient
por: Invernizzi, Rosangela, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_sgl558uo3c6pfksor5q2ikrri7